Source: Pharmaceuticals. Unidade: IFSC
Subjects: PLANEJAMENTO DE FÁRMACOS, TOXOCARA CANIS, RESISTÊNCIA MICROBIANA ÀS DROGAS
ABNT
SILVA, Tais C. et al. Phenotypic screening of H1-antihistamines identifies promethazine and rupatadine as active compounds against Toxocara canis infective larvae. Pharmaceuticals, v. 18, n. 7, p. 997-1-997-14 + supplementary materials, 2025Tradução . . Disponível em: https://doi.org/10.3390/ph18070997. Acesso em: 24 jan. 2026.APA
Silva, T. C., Silva, J. G., Amaro, M. C., Silva-Silva, J. V., Döring, T. H., Ferreira, L. L. G., et al. (2025). Phenotypic screening of H1-antihistamines identifies promethazine and rupatadine as active compounds against Toxocara canis infective larvae. Pharmaceuticals, 18( 7), 997-1-997-14 + supplementary materials. doi:10.3390/ph18070997NLM
Silva TC, Silva JG, Amaro MC, Silva-Silva JV, Döring TH, Ferreira LLG, Andricopulo AD, Moraes J de. Phenotypic screening of H1-antihistamines identifies promethazine and rupatadine as active compounds against Toxocara canis infective larvae [Internet]. Pharmaceuticals. 2025 ; 18( 7): 997-1-997-14 + supplementary materials.[citado 2026 jan. 24 ] Available from: https://doi.org/10.3390/ph18070997Vancouver
Silva TC, Silva JG, Amaro MC, Silva-Silva JV, Döring TH, Ferreira LLG, Andricopulo AD, Moraes J de. Phenotypic screening of H1-antihistamines identifies promethazine and rupatadine as active compounds against Toxocara canis infective larvae [Internet]. Pharmaceuticals. 2025 ; 18( 7): 997-1-997-14 + supplementary materials.[citado 2026 jan. 24 ] Available from: https://doi.org/10.3390/ph18070997
